Abstract:Background 8‐Oxo‐2′‐deoxyguanosine (8‐oxo‐2′‐dG) is a biomarker of oxidative DNA damage that is associated with cardiovascular disease and premature mortality in the general population. Although oxidative stress has a proven role in cardiovascular complications in diabetes mellitus, evidence for a relationship between plasma 8‐oxo‐2′‐dG and major cardiovascular outcomes in diabetes mellitus is weak. Methods and Results A case‐cohort study was performed in 3766 participants with prevalent diabetes mellitus in the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) trial (http://ClinicalTrials.gov number NCT00145925). The hazard ratios for mortality and major acute cardiovascular events were derived using Cox regression models. During a median of 5 years of follow‐up, 695 (18.4%) participants in this enriched cohort died (including 354 deaths from cardiovascular disease). Individuals with higher levels of 8‐oxo‐2′‐dG were more likely to die. After adjusting for cardiovascular disease risk factors, the hazard ratio for a 1‐SD increase in plasma 8‐oxo‐2′‐dG was 1.10 (95% confidence interval, 1.01–1.20; P=0.03). This was driven by an independent association between plasma 8‐oxo‐2′‐dG and cardiovascular death (hazard ratio, 1.23; 95% confidence interval, 1.10–1.37 [P<0.001]). By contrast, no association was seen between 8‐oxo‐2′‐dG and noncardiovascular disease death (of which cancer was the major single cause). 8‐Oxo‐2′‐dG was also not significantly associated with either nonfatal myocardial infarction or nonfatal stroke. Conclusions In adults with type 2 diabetes mellitus, increased levels of 8‐oxo‐2′‐dG are independently associated with all‐cause mortality and cardiovascular mortality in adults with longstanding type 2 diabetes mellitus who participated in the ADVANCE trial, consistent with the role of oxidative damage in the development and progression of cardiovascular decompensation in diabetes mellitus. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT00145925.

Relationship between serum levels of 8-OHdG and macrovascular complications in type-2 diabetes patients

The clinical research about the relationship between serum levels of 8-hydroxy-deoxyguanosine (8-OHdG) of type 2 diabetes patients and its macrovascular complications

Study on the relationship between DNA oxidative damage and macrovascular complications in patients with type 2 diabetes

Relationship of Type 2 Diabetes Mellitus with Microangiopathy and Oxidative Damage of DNA

Increased 8-Hydroxy-2'-deoxyguanosine in Leukocyte DNA from Patients with Type 2 Diabetes and Microangiopathy.

Impact of Increased Serum 8-Hydroxy-2′-deoxyguanosine Levels on Extent of Coronary Artery Lesions in Elderly Patients with Type 2 Diabetes

Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

The association between glycemic variability and oxidative stress in type 2 diabetic patients with carotid atherosclerosis

The Relationship Between the Early Atherosclerosis and Oxidative Stress in the Populations with Abnormal Glucose Metabolism and Study of Its Mechanisms

Correlation of Serum 8-Ohdg with Insulin Resistance and Intima-Media Thickness of the Carotid Artery in Type 2 Diabetic Patients

Relationship between serum lutein and oxidative stress in patients with type 2 diabetes mellitus

Serum 8-hydroxy-2′-deoxyguanosine (8-oxo-dG) levels are elevated in diabetes patients

Significance of Serum 8-Hydroxydeoxyguanosine Levels to the Intima-Media Thickness of the Carotid Artery in Type 2 Diabetes

Relationship between serum markers of oxidative stress and early stage diabetic nephropathy as well as metabolic syndrome

Urinary 8-Hydroxydeoxyguanosine Levels in Diabetic Retinopathy Patients

Relationship Between Blood Level of Homocysteine and Macroangiopathy in Patients With Type 2 Diabetes Mellitus

High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study

Correlation Analysis between Serum Vitamin D Levels and Lower Extremity Macrovascular Complications in Individuals with Type 2 Diabetes Mellitus

Changes of serum 25 hydroxyvitamin D 3 expression in diabetic patients and its correlation with macrovascular complications

Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial